Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
tell the IRS to buy 25K of POSC and when it goes to .10 they have their 2K
There is my boy CSTI low offer as usual........wish he would take a few days off from holding POSC down.
thanks for the info
I was not disputing that they would control it. i believe i was commenting on the secret signal through small buys was a bit out there.
BAMMM CSTI back on offer at .0598 when we are trading at .063. it appears they want to keep the price below .06....WHY? Trying to suppress the stock because they are short? any guesses?
no i have heard they are big over seas
there they are again .0598. it does not seem like they are a big firm, at least not on the US. but they have been selling tons of stock over the last few weeks. and very aggressively. How much more do they have is the big question. maybe it is the 8.5 million awarded from the settlement.
Once again we trade at .06 and CSTI goes low offer at .058. Makes no sense. they could be low offer at .059 or let the stock go up some and sell. they seem to pressure the offer.
they obviously have to file to sell shares.
i have not seen any .06 bids. the high on the day was .0594
anyone else seeing CSTI on level 2 constantly low offer? we trade up to .057 and they load offer again at .056. they are holding us back.
OK the "E" is off. lets get some news out and buying going.
Interesting Email from POSc and one investors take on it.
Following from ymb
The REAL DEAL. Email Received from Investor Relations!!! 2-Sep-10 01:34 pm The most successful investor in the history of the market, Warren Buffet, said that you buy growth stocks when everyone else is scared and selling. Since POSC has such a promising future, developing cutting edge radiopharmacy equipment/drugs, award winning PET Scanners, and a confirmed relationship with Covidien (Multi-Billion Corp.)..then how in the heck can you not see growth or huge orders coming? POSC is at an extremely low FIRE SALE PRICE right now. The truth is that so many things are on the fast track to deployment...within weeks IMO. It's an incredible time to purchase POSC stock. Today, I just loaded up at .051 and averaged my position down tremendously.
Here is an email from Patrick Rooney/Investor Relations:
-Is there going to be an announcement in the near future letting all of us know about the details of this “alliance” with Covidien?
More may be announced when and if it is deemed necessary. For competitive reasons either company will be selective in its public statements. (MY TAKE: THERE IS A BIG RELATIONSHIP AND EVERYONE IS KEEPING QUIET BECAUSE THEY DON'T WANT THEIR COMPETITORS IN ON IT UNTIL DEPLOYMENT AND SALES BEGIN. SMART MOVE).
-Is Covidien going to discuss the details of this alliance publicly in the near future?
Not sure this is their call. I believe they will let the execution of our plan speak for itself. (MY TAKE: COVIDIEN KNOWS EXACTLY WHAT THEY ARE DOING. WHEN SALES AND DISTRIBUTION AGREEMENTS AND ANNOUCNED BY COV...THEN THE WORLD WILL KNOW WHAT'S GOING ON. FOR NOW..WE'RE VERY CLOSE..BUT IT'S BEING KEPT QUIET).
-Is there any news to report regarding the 2nd NYSE company that you hinted there was a relationship with?
We are working with a number of companies that we fill their need for a solution. No one in particular.(MY TAKE: THIS IS A GREAT SIGN. ORDERS FROM MULTIPLE COMPANIES).
-Is Positron planning on providing some forward looking financial outlooks…including any forecasted revenue and income from PET’s and the radiopharmacies given these new relationships and rapid growth?
Once we can. We are in a strong growth mode though. More to follow is a safe bet.(MY TAKE: THIS IS EXCELLENT. THEY ARE IN A "STRONG GROWTH" MODE. YOU DON'T HEAR THAT TOO OFTEN).
-When are the new radiopharmacy units expected to be completed and delivered to Covidien?
We will be launching within weeks.(MY TAKE: LAUNCHING WITHIN WEEKS?? AWESOME).
-And finally, I just saw that Positron has job announcements out for a Chemist and Radiopharmacy staff at one of your new buildings. Are you able to provide a business update regarding that status of the company, what the various facilities will be used for and what kind of staff is being hired and why?
Dam you good. This is a telling tale for investors putting pieces together. Our manufacturing plant is up and running and we need personnel to expand. I cannot comment much more on this at this time.
(MY TAKE: GUESS WHAT? THE CEO OF POSITRON JUST ADMITTED THAT HUGE THINGS ARE HAPPENING...AND THAT THOSE OF US WHO PUT THE PIECES OF THE PUZZLE TOGETHER WILL BE GREATLY REWARDED. A MANUFACTURING PLANT IS UP AND RUNNING AND THEY ARE HIRING A LOT OF STAFF TO RAMP EVERYTHING UP).
Why would Covidien be involved if they did not see huge potential in this business plan in the near future? COV likes to take their time and develop a relationship with a partner company before they buy them out. Ignore the MM's, ignore those who are scared and who are panic selling, and if you think you want to invest in what seems to be a promising future for POSC...go for it if you are financially able to. There will never be a better time to load up on cheaper shares than right now. More big news will probably be announced within weeks. GOOD LUCK TO ALL LONGS.
no data but there are some new names. some people change their aliases occassionally
people who got caught up in the hype and put too much money into a RUMOR on bmr paid too much. they need someone to blame because it could never be there fault.
Definition of RUMOR
1: talk or opinion widely disseminated with no discernible source
2: a statement or report current without known authority for its truth
if this was the basis for your investment that you thought you had inside info from a website.
thats on you.....OWN IT AND MOVE ON.
i think we are slowly in the process of recovery. short termers looking for a buyout from bmr have given up. bid support building. a news release or 2 and we should get some traction. short term pet sales, medium term pharma expansion. longer term big 10qs.
i think the strom has passed.
without knowing the details of the transaction, i.e. the buyer and relationship. you are making a lot of assumptions. why don't you man up email or call the ceo. he does not hide.
I think that the new site will be a source of good news in the weeks to come. There are many different irons in the fire. the COV iron will only get bigger and better but it will take time.
stay tuned, I expect we will all be pleasantly surprised in the other developments as they play out with more of an immediate increase in revenue and I expect PPS as well.
Investors can see the big picture before it is in plain site.
short term traders just want big news and price jumps.
which are you?
we seem to be making lower lows each day. i don't get it.
Could Bracco be a player in this story??
Bracco Imaging S.p.A., part of the Bracco Group, is one of the World's leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs and facilitate clinical solutions.
Bracco Imaging is a subsidiary of Bracco S.p.A, the holding company of the Bracco Group, which also markets Ethical and Over The Counter (OTC) pharmaceutical products in Italy as well as Advanced Medical Technology systems worldwide. Furthermore, the Bracco Group offers diagnosis services through the Milan-based Centro Diagnostico Italiano (Italian Diagnostic Center).
Bracco Imaging is the only global diagnostic imaging player dedicated to the development of imaging agent and solutions. Imaging agents are pharmaceuticals used to allow diagnosis and monitoring of disease.
Bracco Imaging's portfolio offering has recently been broadened with the acquisition of E-Z-EM, Inc., a major manufacturer of contrast media and medical devices for gastrointestinal (GI) radiology. The portfolio of Bracco Imaging offers products and solutions for all key diagnostic imaging modalities: X-Ray Imaging (including Computed Tomography-CT), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound, and Nuclear Medicine through radioactive tracers.
The Company operates in over 80 markets worldwide, either directly or indirectly, through subsidiaries, joint ventures, licenses and distribution partnership agreements. With an ongoing research covering all key modalities, Bracco Imaging has a strong presence in key geographies: North America, through Bracco Diagnostics Inc. headquartered in Princeton, NJ, and with an affiliate in Toronto (Canada); Europe, with offices in all major countries; Japan, where it operates through a licensing agreement with Bayer Schering and the Joint Venture BRACCO-EISAI Co., Ltd.. Furthermore, it operates in China through its 70% controlled Joint Venture, Bracco Sine Pharmaceutical Corp. Ltd., and an office in Beijing.
Operational investments have been made by Bracco Imaging in order to achieve top quality and compliances with a sustainable ecology friendly production. Manufacturing activities are located in Italy (Ceriano Laghetto, Torviscosa, and Ivrea), Switzerland (Geneva), Japan (Saitama) and China (Shanghai).
Bracco Imaging is an innovative R&D player with an efficient process oriented approach and a track record of innovation in the diagnostic imaging industry. R&D activities are managed in three Research Centers located in Colleretto Giacosa (Italy), Geneva (Switzerland), and Princeton, NJ (US). Each Research Center possesses highly specialized expertise in diverse diagnostic imaging modalities and techniques. Additional development expertise and support functions exist in Milan, Beijing, Konstanz (Germany) and Tokyo (Japan). Bracco Imaging also has a number of research collaboration agreements with prestigious University Departments, Hospital-based Research Centers and Biotech Companies in various parts of the world.
Dr Gould will be the keynote speaker at the upcoming conference. the FOREMOST expert on cardiac PET and RB-82 (Rubidium).
Joseph Oliverio, chief technical officer of Positron states, "We are honored to have the world's foremost expert on Cardiac PET and quantitative imaging with Rb-82 speak at our symposium. Dr. Gould's talk will update the audience on the growing new paradigm for cardiac imaging as the guide to managing coronary artery disease, which is also the basis for the future release of our new comprehensive quantitative workstation."
"PET is a clear window into the heart - its past, present and future. It's a critical tool that provides the clarity and insight needed to treat and prevent coronary artery disease," stated Dr. Gould.
POSC has products that will dipsense Rubidium.
Our Nuclear Cardio-Assist provides nuclear cardiology departments the ease of "Unit Dose" with the reliability of an "In-House" supply. The Nuclear Cardio-Assist automatically elutes a generator, compounds kits, performs quality control, fills a syringe, assays the dose in the syringe and dispenses the dose in the syringe ready for patient injection. The Nuclear Cardio-Assist? replaces typical "Hot" lab equipment and acts as a "virtual" nuclear pharmacy with "Unit Dose" availability, at the touch of a button, 24/7
Here is the problem with that. How does it help COV right now? Why would they put out a release with the sole purpose of helping the PPS of an OTCBB company. that just does not happen. When the partnership evolves or grows to a point where the revenue is a positive for COV, then I expect it will be released.
There was an NT 10Q filed Aug 16. They had 15 calender days to file the 10Q. It was filed Aug 23 and a 10Q A on Aug 24. they should not have an E
IMO, not until it adds significantly to the bottom line for COV. However. POSC can give updates now that the deal is public
Why is is so hard for this company to file its financials on time?
the best chance for that is Sept 15 at their investor conference, but i would not hold my breath. i give it a 15% chance they say anything about it.
i think there are a lot of people who bought the stock on hype. not actual investors that put time into research and their own due dilligence. they bought because they thought they had some inside info feom BMR that COV was buying POSC. So now that we know that is not the case and they are in over their head and probably down significantly. once the weak hands are gone and the partnershis develops, along with other sales and revenue. we will see much higher pps.
Nice bounce back. Bid support swelling.
there needs to be more consitent news and market support to go with it. in the penny stock world, no news is bad news, there are thousands of other companys putting out news which attracts buying.
has anyone seen the chart? looks like a ski slope.
.06 bid. we need some news and buying
definatley
I do not expexct COV will be discussing the POSC deal at their investor conference. just my opinion. I thnk further updates on that deal will be from POSC
Here is a link to the conference POSC will be presenting at
http://www.rodm.com/conferences?id=51
i agree, but some peole have stated a concern about it.
I would not be surprised if we hear that the COV parrtnership evolves into something far bigger
I have been assured that at the VERY LEAST. there will be no reverse spilt over the next 6 months. The only reason that would even come into play is if there was a planned listing on a higher exchange like NASDQ or AMEX. Not an option at this time
great job vince .02 bid
Publicly traded companies typically discount the common stock when they raise capital. It dosen't neccessarily mean he thinks that is what the stock is worth.